Preparing clinical care for Winter 2025.
The H3N2 influenza virus poses a significant concern for this winter due to its potential for increased severity and high transmission rates, especially in vulnerable populations. Historically, H3N2 strains have been associated with more severe illness and a higher risk of complications. New mutations and variation in vaccine uptake may lead to increased numbers of patients in severe respiratory failure, both from primary and secondary infections. Intensive Care Units are starting to feel the strain on capacity, and this is at the beginning of winter. This webinar will provide a rapid clinical review of what clinicans need to know to manage patients, keep themselves and staff safe, communicate with families, other professionals and local networks, and implement learnings from the COVID pandemic.





Consultant Intensivist
Dr Conway Morris is a critical care consultant and MRC Clinician Scientist based at the University of Cambridge. He trained at the Universities of Glasgow and Edinburgh, undertaking a PhD in Edinburgh focused on immune failure in critical illness and nosocomial infection. His research interests include neutrophil function and dysfunction in critical illness, where he identified complement component C5a as a key driver of dysfunction in patients. He has also developed and tested a number of diagnostics for pneumonia, using both host and pathogen-focussed techniques. His animating force is a desire to improve the management of infection in intensive care, and combat the rising tide of antimicrobial resistance. He was recently awarded the Royal College of Anaesthetists 2023 Mackintosh Professorship. He is the director of the European Society of Intensive Care Medicine’s research and antimicrobial stewardship learning pathways.

ICS President and Consultant Intensivist , UK
Shondipon is a Consultant in intensive care and anaesthesia at Lancashire Teaching Hospitals NHS Foundation Trust and the Intensive Care Society's Honorary Secretary. He is also the Society's Learning Division Chair leading the education and ultrasound programme across the UK.
:
www.ics.ac.uk
:
@shond3

Consultant in Microbiology and Infectious Diseases
I am a UKHSA Consultant in Infectious Disease and Microbiology based at the Bristol Royal Infirmary.
I completed my infection training in Oxford and Singapore and I'm the Vice President of the British Infection Society - I have recently initiated a collaboration with the Intensive Care Society to optimise the delivery of infection services within critical care.
I am the microbiology ECMO lead at the Bristol Royal Infirmary.
My other clinical and academic interests are adult vaccines, sustainability in healthcare and tuberculosis.

Consultant Intensivist and Anaesthetist
Dr Patel graduated with distinction honours from University College London Medical School. He trained in general internal medicine at the former Royal Postgraduate Medical School at Hammersmith Hospital, before pursuing clinical training in anaesthesia and intensive care medicine through Guy’s and St Thomas’ Hospitals.
Dr Patel successfully attained a Clinical Research Training Fellowship from the Wellcome Trust to undertake a PhD within Imperial College London. His PhD investigated the role of tumour necrosis factor (TNF), which subsequently won institutional and regional prizes, including the Gold Medal for Research from the Intensive Care Society (UK) in 2011/12.
Following completion of his PhD, Dr Patel went on to complete advanced training in Intensive Care Medicine through the Royal Brompton and King’s College Hospitals. In 2014, he was appointed as a clinical lecturer in anaesthesia and intensive care at the National Institute of Health Research (NIHR).
Dr Patel is as an honorary consultant with adult intensive care at Royal Brompton and Harefield hospitals. He is a clinical senior lecturer at Imperial College London.
Please accept {{cookieConsents}} cookies to view this content